Literature DB >> 20398912

Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition.

Pranee Somboonthum1, Tetsuo Koshizuka, Shigefumi Okamoto, Masaaki Matsuura, Yasuyuki Gomi, Michiaki Takahashi, Koichi Yamanishi, Yasuko Mori.   

Abstract

Using a rapid and reliable system based on Tn7-mediated site-specific transposition, we have successfully constructed a recombinant Oka varicella vaccine (vOka) expressing the mumps virus (MuV) fusion protein (F). The backbone of the vector was our previously reported vOka-BAC (bacterial artificial chromosome) genome. We inserted the transposon Tn7 attachment sequence, LacZalpha-mini-attTn7, into the region between ORF12 and ORF13 to generate a vOka-BAC-Tn genome. The MuV-F expressing cassette was transposed into the vOka-BAC genome at the mini-attTn7 transposition site. MuV-F protein was expressed in recombinant virus, rvOka-F infected cells. In addition, the MuV-F protein was cleaved in the rvOka-F infected cells as in MuV-infected cells. The growth of rvOka-F was similar to that of the original recombinant vOka without the F gene. Thus, we show that Tn7-mediated transposition is an efficient method for introducing a foreign gene expression cassette into the vOka-BAC genome as a live virus vector. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398912     DOI: 10.1016/j.virol.2010.03.032

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression.

Authors:  Masaaki Matsuura; Masaya Takemoto; Koichi Yamanishi; Yasuko Mori
Journal:  Virol J       Date:  2011-01-11       Impact factor: 4.099

Review 2.  Back to BAC: the use of infectious clone technologies for viral mutagenesis.

Authors:  Robyn N Hall; Joanne Meers; Elizabeth Fowler; Timothy Mahony
Journal:  Viruses       Date:  2012-02-03       Impact factor: 5.048

3.  Recombinant varicella-zoster virus vaccines as platforms for expression of foreign antigens.

Authors:  Wayne L Gray
Journal:  Adv Virol       Date:  2013-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.